期刊文献+

疑难病例析评第148例 血小板下降——抽搐——肾功能衰竭 被引量:1

原文传递
导出
摘要 病历 摘要患者女,19岁,因关节肿痛2个月、蝶形红斑7d、发热1d 于2006年10月19日人院。患者于2006年8月无明显诱因出现全身多关节肿痛伴晨僵。并出现心悸,双下肢对称性可凹性水肿。就诊当地医院,查血常规:白细胞计数3.4×10^9’/L;心电图示Ⅱ度房室传导阻滞。
出处 《中华医学杂志》 CAS CSCD 北大核心 2008年第13期923-926,共4页 National Medical Journal of China
  • 相关文献

参考文献10

  • 1Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol, 1992, 19: 508-512.
  • 2Asherson RA. The catastrophic antiphospholipid ( Asherson' s ) syndrome. Autoimmun Rev, 2006, 6:64-67.
  • 3Asherson RA, Cervera R, De Groot PG, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus, 2003,12 : 530-534.
  • 4Erkan D, Cervera R, Asherson RA. Catastrophic antiphospholipid syndrome. Where do we stand? Arthritis Rheum, 2003, 48:3320- 3327.
  • 5Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine, 1998,77 : 195-207.
  • 6Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine, 2001, 80:355-377.
  • 7Bucciarelli S, Espinosa G, Cervera R, et al. Mortality in the catastrophic antiphospholipid syndrome: prognostic factors in a series of 250 patients. Arthritis Rheum, 2006, 54 : 2568-2576.
  • 8Bucciarelli S, Cervera R, Espinosa G, et al. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors. Autoimmun Rev, 2006, 6:72-75.
  • 9Sinha J, Chowdhry I, Sedan S, et al. Bone marrow necrosis and refractory HELLP syndrome in a patient with catastrophic antiphospholipid antibody syndrome. J Rheumatol, 2002, 29 : 195- 197.
  • 10Boura P, Papadopoulos S, Tselios K, et al. Intracerebral hemorrhage in a patient with SLE and catastrophic antiphospholipid syndrome (CAPS) : report of a case. Clin Rheumatol, 2005,24 : 420-424.

同被引文献11

  • 1Koulaouzidis A, Bhat S, Gopal K. Retroperitoneal fibrosis. CMAJ, 2007, 177 : 1027.
  • 2Corradi D, Maestri R, Palmisano A, et al. Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int ,2007,72:742-753.
  • 3Reilly RF. Retroperitoneal fibrosis presenting as acute renal failure. Nat Clin Pract Nephrol,2005 ,1:55-59.
  • 4Cavalleri A, Brunner P, Monticelli I, et al. CT-guided biopsy in two cases of retroperitoneal fibrosis. Clin Imaging,2008,32:230- 232.
  • 5Fry AC, Singh S, Gunda SS, et al. Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperitoncal fibrosis: a retrospective study. Nephron Clin Pract, 2008,108 : 213-220.
  • 6Ergun I, Keven K, Canbakan B, et al. Tamoxifen in the treatment of idiopathic retroperitoneal fibrosis. Int Urol Nephrol, 2005,37 : 341-343.
  • 7Swartz RD, Lake AM, Roberts WW, et al. Idiopathic retroperitoneal fibrosis: a role for mycophenolate mofetil. Clin Nephrol, 2008,69:260-268.
  • 8Khalil F, Mir MA, Venuto RC. Mycophenolate mofetil in the treatment of retroperitoneal fibrosis. Clin Rheumatol, 2008,27: 679-681.
  • 9Srinivasan AK, Richstone L, Permpongkosol S, et al. Comparison of laparoscopic with open approach for ureterolysis in patients with retroperitoneal fibrosis. J Urol,2008,179 : 1875-1878.
  • 10Wolyniec W, Kozuchowska M, Sworczak K, et al. When can we really diagnose idiopathic retroperitoneal fibrosis? Nephrol Dial Transplant, 2007,22 : 1786-1787.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部